semaglutide / tirzepatide Semaglutide, recommended as first-line treatment of obesity and most of its complications in new guidance what is difference between semaglutide

Some states welcome psychiatric providers prescribing weight-loss meds

Zepbound received FDA approval in November 2023 specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition, such as hypertension or dyslipidemia

Ultra Seal Corporations facilities in New Paltz, NY, were inspected between Aug

Mechanism of oxidative stress in neurodegeneration

Clinical Update 6/27/2020 Factors For Lower Risk of Dementia Diet and lifestyle factors were associated with up to 60% reductions in the risk of developing Alzheimer dementia according to a new study

An attempt at explaining the TREAT study results: Ein Versuch, die Resultate der TREAT-Studie zu erklren